135 results
Page 4 of 7
424B5
mi8 3wgdef
4 Mar 08
Prospectus supplement for primary offering
12:00am
424B5
5mq9r8qs9s
16 Jan 08
Prospectus supplement for primary offering
12:00am
424B5
df3bt2xj
3 Dec 07
Prospectus supplement for primary offering
12:00am
424B5
qfu947yzef
12 Oct 07
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
6xd 3dko21pdc
21 Aug 07
Cell Therapeutics, Inc. (CTI) Enters Agreement to Acquire
12:00am
424B5
qoi9b7bl2i0g13ww0
27 Jul 07
Prospectus supplement for primary offering
12:00am
8-K
EX-2.1
e20f38jrv f6gd4
27 Jul 07
Cell Therapeutics, Inc. (CTI) Announces Agreement to Acquire SMi; Gains Global Rights to Brostallicin, in a New Class of Cancer Killing Agents
12:00am
424B5
xxyy ex015lnqbd
13 Apr 07
Prospectus supplement for primary offering
12:00am
424B5
frg1yy
14 Feb 07
Prospectus supplement for primary offering
12:00am
424B5
t6ok76y7bmg4np
12 Feb 07
Prospectus supplement for primary offering
12:00am
424B5
xl9 t56v95mx9
20 Sep 06
Prospectus supplement for primary offering
12:00am
424B5
4wgnxjut8yozgghd4u
25 Apr 06
Prospectus supplement for primary offering
12:00am
424B3
xemez 946cj5l
7 Oct 05
Prospectus supplement
12:00am
POS AM
kjhf 31oq
13 Sep 05
Prospectus update (post-effective amendment)
12:00am